Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial.
Piliang M, Lynde C, King B, Mirmirani P, Sinclair R, Senna M, Forman S, Bordone L, De La Cueva Dobao P, Wolk R, Zwillich SH, Tran H, Wajsbrot D, Ahmed HM, Takiya L. Piliang M, et al. Among authors: lynde c. J Am Acad Dermatol. 2024 Oct 16:S0190-9622(24)03006-8. doi: 10.1016/j.jaad.2024.09.064. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39423930
Correction: Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
Korge B, Vanhooteghem O, Lynde CW, Machovcova A, Perrussel M, Lazaridou E, Marasca C, Sarro DV, Pousa ID, Fierens F, Williams P, Shimizu S, Heidbrede T, Warren RB. Korge B, et al. Among authors: lynde cw. Dermatol Ther (Heidelb). 2024 Oct;14(10):2923-2926. doi: 10.1007/s13555-024-01271-4. Dermatol Ther (Heidelb). 2024. PMID: 39340697 Free PMC article. No abstract available.
Considerations for defining and diagnosing generalized pustular psoriasis.
Prajapati VH, Lynde CW, Gooderham MJ, Hong HC, Kirchhof MG, Lansang P, Ringuet J, Turchin I, Vender R, Yeung J, Papp KA. Prajapati VH, et al. Among authors: lynde cw. J Eur Acad Dermatol Venereol. 2024 Sep 6. doi: 10.1111/jdv.20310. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39239977 Review.
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial.
Armstrong AW, Gooderham M, Lynde C, Maari C, Forman S, Green L, Laquer V, Zhang X, Franchimont N, Gangolli EA, Blau J, Zhao Y, Zhang W, Srivastava B, Heap G, Papp K. Armstrong AW, et al. Among authors: lynde c. JAMA Dermatol. 2024 Oct 1;160(10):1066-1074. doi: 10.1001/jamadermatol.2024.2701. JAMA Dermatol. 2024. PMID: 39167366 Free PMC article. Clinical Trial.
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1).
King B, Senna MM, Mesinkovska NA, Lynde C, Zirwas M, Maari C, Prajapati VH, Sapra S, Brzewski P, Osman L, Hanna S, Wiseman MC, Hamilton C, Cassella J. King B, et al. Among authors: lynde c. J Am Acad Dermatol. 2024 Jul 23:S0190-9622(24)02550-7. doi: 10.1016/j.jaad.2024.06.097. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39053611 Free article.
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
Blauvelt A, Guttman-Yassky E, Lynde C, Khattri S, Schlessinger J, Imafuku S, Tada Y, Morita A, Wiseman M, Kwiek B, Machkova M, Zhang P, Linaberry M, Li J, Zhang S, Franchin G, Charles ED, De Oliveira CHMC, Silverberg JI. Blauvelt A, et al. Among authors: lynde c. JAMA Dermatol. 2024 Aug 1;160(8):856-864. doi: 10.1001/jamadermatol.2024.2131. JAMA Dermatol. 2024. PMID: 39018038 Free PMC article. Clinical Trial.
Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study.
Korge B, Vanhooteghem O, Lynde CW, Machovcova A, Perrussel M, Lazaridou E, Marasca C, Sarro DV, Pousa ID, Fierens F, Williams P, Shimizu S, Heidbrede T, Warren RB. Korge B, et al. Among authors: lynde cw. Dermatol Ther (Heidelb). 2024 Aug;14(8):2077-2092. doi: 10.1007/s13555-024-01210-3. Epub 2024 Jun 27. Dermatol Ther (Heidelb). 2024. PMID: 38937404 Free PMC article.
312 results